Skip to content

Cell Source, Inc.: 10-Q filed 2020-11-13

What Cell Source, Inc. reported in its quarterly report filed 2020-11-13 (fiscal Q3 2020): 22 published measures, 68 facts as tagged in accession 0001640334-20-002809.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-13
Fiscal period
fiscal Q3 2020
Accession
0001640334-20-002809 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-30210,329USD
At 2019-12-31114,783USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-307,228,760USD
At 2019-12-315,856,724USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30-7,018,431USD
At 2020-06-30-6,528,017USD
At 2020-03-31-6,257,870USD
At 2019-12-31-5,741,941USD
At 2019-09-30-5,914,548USD
At 2019-06-30-5,153,771USD
At 2019-03-31-5,111,461USD
At 2018-12-31-4,920,171USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3054,736USD
At 2019-12-3127,908USD
At 2019-09-308,831USD
At 2018-12-3118,934USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-3,286,065USD274
2019-01-01 to 2019-09-30-3,899,460USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-2,018,019USD274
2019-01-01 to 2019-09-30-1,723,872USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-302,044,847USD274
2019-01-01 to 2019-09-301,713,769USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-24,431,893USD
At 2019-12-31-21,145,828USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-30319,396USD274
2019-01-01 to 2019-09-301,750USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-1,165,645USD92
2020-01-01 to 2020-09-30-2,802,308USD274
2019-07-01 to 2019-09-30-1,360,996USD92
2019-01-01 to 2019-09-30-3,261,936USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-307,228,760USD
At 2019-12-315,711,724USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-30376,346USD
At 2019-12-31135,415USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2020-01-01 to 2020-09-300USD274
2019-01-01 to 2019-09-301,000USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,165,645USD92
2020-01-01 to 2020-09-302,802,308USD274
2019-07-01 to 2019-09-301,360,996USD92
2019-01-01 to 2019-09-303,261,936USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3029,965,043shares
At 2019-12-3127,076,762shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-3017,382,155USD
At 2019-12-3115,375,565USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-301,037,866USD
At 2019-12-311,051,961USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-1,307,630USD92
2020-01-01 to 2020-09-30-3,286,065USD274
2020-04-01 to 2020-06-30-1,164,688USD91
2020-01-01 to 2020-03-31-813,747USD91
2019-07-01 to 2019-09-30-1,487,966USD92
2019-01-01 to 2019-09-30-3,899,460USD273
2019-04-01 to 2019-06-30-952,985USD91
2019-01-01 to 2019-03-31-1,458,509USD90

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-1,533,821USD92
2020-01-01 to 2020-09-30-3,935,446USD274
2019-07-01 to 2019-09-30-1,685,877USD92
2019-01-01 to 2019-09-30-4,434,379USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30908,099USD92
2020-01-01 to 2020-09-302,015,624USD274
2019-07-01 to 2019-09-30168,906USD92
2019-01-01 to 2019-09-30909,334USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-141,985USD92
2020-01-01 to 2020-09-30-483,757USD274
2019-07-01 to 2019-09-30-126,970USD92
2019-01-01 to 2019-09-30-637,524USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30240,931USD274
2019-01-01 to 2019-09-30170,737USD273

Inspect the source

Entity
Cell Source, Inc. / CIK 0001569340
Captured
2026-09-20T09:20:59.488Z
SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))